Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies

References

• Anasetti C, Amos D, Beatty P G, Appelbaum F R, Bensinger W, Buckner C D, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197–204
   PubMed Web of Science ®Google Scholar
• Anasetti C, Beatty P G, Storb R, Martin P J, Mori M, Sanders J E, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79–91
   PubMed Web of Science ®Google Scholar
• Beatty P G, Clift R A, Mickelson E M, Nisperos B B, Flournoy N, Martin P J, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765–771
   PubMed Web of Science ®Google Scholar
• Deschamps I, Lestradet H, Bonaiti C, Schmid M, Busson M, Benajam A, et al. HLA genotype studies in juvenile insulin-dependent diabetes. Diabetologia 1980; 19: 189–193
   PubMed Web of Science ®Google Scholar
• Wordsworth B P, Lanchbury J S, Sakkas L I, Welsh K I, Panayi G S, Bell J I. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989; 86: 10049–10053
   PubMed Web of Science ®Google Scholar
• Ronningen K S, Spurkland A, Egeland T, Iwe T, Munthe E, Vartdal F, et al. Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67–74. Tissue Antigens 1990; 36: 235–240
   PubMed Web of Science ®Google Scholar
• Dunckley H, Chapman J R, Burke J, Charlesworth J, Hayes J, Haywood E, et al. HLA-DR and -DQ genotyping in anti-GBM disease. Dis Markers 1991; 9: 249–256
   PubMed Web of Science ®Google Scholar
• Sacchetti L, Tinto N, Calcagno G, Improta P, Salvatore F. Multiplex PCR typing of the three most frequent HLA alleles in celiac disease. Clin Chim Acta 2001; 310: 205–207
   PubMed Web of Science ®Google Scholar
• van Zeben D, Hazes J M, Zwinderman A H, Cats A, Schreuder G M, D'Amaro J, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum 1991; 34: 822–830
   PubMed Web of Science ®Google Scholar
• Rosloniec E F, Brand D D, Myers L K, Esaki Y, Whittington K B, Zaller D M, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998; 160: 2573–2578
   PubMed Web of Science ®Google Scholar
• Rosloniec E F, Whittington K B, He X, Stuart J M, Kang A H. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Am J Med Sci 2004; 327: 169–179
   PubMed Web of Science ®Google Scholar
• Lee S J, Klein J, Haagenson M, Baxter-Lowe L A, Confer D L, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576–4583
   PubMed Web of Science ®Google Scholar
• Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197–1203
   PubMed Web of Science ®Google Scholar
• Bross D S, Tutschka P J, Farmer E R, Beschorner W E, Braine H G, Mellits E D, et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 1984; 63: 1265–1270
   PubMed Web of Science ®Google Scholar
• Smyth L A, Witt C S, Christiansen F T, Herrmann R P, Hollingsworth P N, Townend D C, et al. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 351–355
   PubMed Web of Science ®Google Scholar
• Storb R, Prentice R L, Hansen J A, Thomas E D. Association between HLA-B antigens and acute graft-versus-host disease. Lancet 1983; 2: 816–819
   PubMed Web of Science ®Google Scholar
• Petersdorf E W, Longton G M, Anasetti C, Martin P J, Mickelson E M, Smith A G, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606–1613
   PubMed Web of Science ®Google Scholar
• Remberger M, Persson U, Hauzenberger D, Ringden O. An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2002; 119: 751–759
   PubMed Web of Science ®Google Scholar
• Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?. Transplant Proc 2004; 36: 3190–3193
   PubMed Web of Science ®Google Scholar
• Ghavamzadeh A, Alimoghaddam K, et al. HLA and Risk of acute graft versus host disease in allogeneic bone marrow transplantation from an HLA identical sibling. Arch Iranian Med 2002; 5: 16–20
   Google Scholar
• Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E, et al. Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence. Blood 2006; 107: 1970–1973
   PubMed Web of Science ®Google Scholar
• Clark R E, Hermans J, Madrigal A, Nachbaur D, Kropshofer G, Gratwohl A, et al. HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 2001; 114: 36–41
   PubMed Web of Science ®Google Scholar
• Adams K M, Holmberg L A, Leisenring W, Fefer A, Guthrie K A, Tylee T S, et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood 2004; 104: 1894–1897
   PubMed Web of Science ®Google Scholar
• DeGast G C, Mickelson E M, Beatty P G, Amos D, Sullivan K M, Schoch H G, et al. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant 1992; 9: 87–90
   PubMed Web of Science ®Google Scholar
• Martin P J, Gooley T, Anasetti C, Petersdorf E W, Hansen J A. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling. Biol Blood Marrow Transplant 1998; 4: 128–133
   PubMedGoogle Scholar
• Benekli M, Hahn T, Williams B T, Cooper M, Roy H N, Wallace P, et al. Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation. Bone Marrow Transplant 2006; 38: 365–370
   PubMed Web of Science ®Google Scholar
• Marsh S G. Nomenclature for factors of the HLA system, update March 2007. Tissue Antigens 2007; 70: 83–85
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, Buckner C D, Neiman P E, Clift R A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304
   PubMed Web of Science ®Google Scholar
• Shulman H M, Sullivan K M, Weiden P L, McDonald G B, Striker G E, Sale G E, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217
   PubMed Web of Science ®Google Scholar
• Overall Severity of Chronic Graft versus Host Disease: IBMTR/ABMTR Reporting Form 002COREc (3/05) Page 23, [Internet]; 2007 18th September] Available from: http://www.ibmtr.org/DATA/PDF/002core.pdf
   Google Scholar
• Hardy G. Mendelian proportions in a mixed population. Science 1908; 28: 49–50
   PubMedGoogle Scholar
• Weinberg W. Über den Nachweis der Vererbung beim Menschen. Jahreshefte des Vereins für vaterländische Naturkunde in Württemberg 1908; 64: 368–382
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mori M, Beatty P G, Graves M, Boucher K M, Milford E L. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997; 64: 1017–1027
   PubMed Web of Science ®Google Scholar
• Horowitz M M, Gale R P, Sondel P M, Goldman J M, Kersey J, Kolb H J, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562
   PubMed Web of Science ®Google Scholar
• Lee S J, Klein J P, Barrett A J, Ringden O, Antin J H, Cahn J Y, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406–414
   PubMed Web of Science ®Google Scholar
• Goldman J M, Gale R P, Horowitz M M, Biggs J C, Champlin R E, Gluckman E, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806–814
   PubMed Web of Science ®Google Scholar
• Enright H, Davies S M, DeFor T, Shu X, Weisdorf D, Miller W, et al. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective. Blood 1996; 88: 714–720
   PubMed Web of Science ®Google Scholar
• van Rhee F, Szydlo R M, Hermans J, Devergie A, Frassoni F, Arcese W, et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 553–560
   PubMed Web of Science ®Google Scholar
• Stern M, Passweg J, Tiercy J M, Genitsch A, Meyer-Monard S, Heim D, et al. Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 1169–1175
   PubMed Web of Science ®Google Scholar
• Holmes J A, Whittaker J A. Histocompatibility antigen DR4 is associated with chronic graft-versus-host disease in the south Wales population. Br J Haematol 1989; 73: 424
   PubMed Web of Science ®Google Scholar
• Pawelec G, Muller C A, Haen M, Ehninger G. Chronic graft-versus-host disease and HLA-DR4 in the southern German population. Br J Haematol 1990; 75: 295–296
   PubMed Web of Science ®Google Scholar